Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound, Wegovy and Eli Lilly
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?
With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more effective? In a press release, Lilly announced that in its latest trial comparing its medication,
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
WebMD
3d
Wegovy vs. Zepbound: New Data Declares a Winner
People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.
1d
Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup
Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
SK pres avoids impeachment
Manslaughter dropped
Wins Grand Prix Final
$965 million verdict upheld
$988M aid package for UKR
Trump on Syria conflict
‘Dynasty' actor dies at 77
To run for top Democrat
Murder suspect recaptured
Threat prompts evacuation
PA grandmother found dead
Producer Maslansky dies
Family awarded $310 million
NFL ends Watson probe
Chipotle raising US prices
WHO probes Congo disease
Drops bid for third term
Taking extended leave
Chinese vessel hijacked
Syrian rebels take Homs
Havana syndrome report
NY museum unveils 'Apex'
Hired as Utah State coach
AI bias meter coming
Romanian election annulled
Climbers feared dead
Fined $25K for gesture
CFPB sues Comerica Bank
Oven gloves recalled
Messi wins MLS MVP award
Ruby slippers sell for $28M
Feedback